Howard.D Hai
Interim Director of Strategy, Chief of Staff at Perpetual Medicines
Howard.D Hai
Interim Director of Strategy, Chief of Staff at Perpetual Medicines
Shanghai
Overview
Work Experience
Vice President, Investment
2023 - Current
Senior Associate, Investment
2022 - 2023
Gordian Ventures is a global life sciences venture firm focused on the incubation of companies with extremely high technical barriers to entry. As co-founders, Gordian Ventures works side-by-side with scientist-entrepreneurs whose insights about overcoming technical barriers are often beyond the scope of the traditional biotech funding model. Our role as active co-founders enables Gordian Ventures to provide embedded, hands-on expertise critical to aligning novel concepts and building visionary companies. We collaborate with our scientific co-founders in the quest to surmount previously unbreakable technical barriers and combat previously intractable diseases that have plagued mankind for millennia. Delivering new age solutions to age-old problems means thinking beyond the limitations of a conventional “magic pill” development cycle of identifying a biology, selecting a target, and attempting to produce a drug to resolve a specific aspect of biology. Gordian Ventures and our scientific co-founders are investing in a new archetype to build companies capable of solving the healthcare problems of today and tomorrow. We are moving at a rapid pace beyond frameworks limited to biology and chemistry and are forging ahead to explore uncharted science at the intersections of multiple technologies to create a healthier future for the people of our planet.
Vice President
2023
Senior Associate
2022 - 2023
Interim Director of Strategy, Chief of Staff
2023
Investor
2022 - 2022
Investor
2020 - 2022
Focus on early-stage pre-clinical therapeutics investment opportunities worldwide. Specify in novel biotechnology platform, FIC small molecule/biologics, and cell/gene therapy. Provide cash and in-kind services (equity-for-service).
Senior Associate
2018 - 2020
- Financial Service - PE/VC Group - Focus on healthcare PE/VC funds - Due Diligence, portfolio valuation, statutory audit, etc.
Assistant Consultant
2017 - 2018